Atenolol overdose successfully treated with hemodialysis-a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251326Keywords:
Atenolol toxicity, Hemodialysis, Hypotension, Hemodynamic instabilityAbstract
Atenolol is a cardio selective beta-blocker and its toxicity often leads to severe hemodynamic instability and contributes to mortality. A significant number of fatal poisonings are caused by beta blockers and supportive therapy is the cornerstone of treatment. We report a case of atenolol toxicity, who had bradycardia and severe hypotension. The patient was administered with high dose insulin therapy, glucagon infusion, lipid emulsion therapy and vasopressors to maintain the mean arterial pressure (MAP) and normal heart rate. Despite these, the patient did not show any clinical improvement. Owing to the favourable hydrophilic and pharmacokinetic characteristics of atenolol, we have administered hemodialysis treatment, with which subsequent improvement in hemodynamic and clinical parameters were observed. The management of atenolol overdose was thus successful with hemodialysis.
Metrics
References
Wadworth AN, Murdoch D, Brogden RN. Atenolol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs. 1991;42:468-510. DOI: https://doi.org/10.2165/00003495-199142030-00007
Alam MA, Awal MA, Subhan N, Mostofa M. In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic. J Health Popul Nutr. 2009;27(1):20-30. DOI: https://doi.org/10.3329/jhpn.v27i1.3315
Patel NP, Pugh ME, Goldberg S, Eiger G. Hyperinsulinemic euglycemia therapy for verapamil poisoning: a review. Am J Crit Care. 2007;16(5):498-503. DOI: https://doi.org/10.4037/ajcc2007.16.5.498
Tolwani AJ, Wheeler TS, Wille KM. Sustained low-efficiency dialysis. Contrib Nephrol. 2007;156:320-4. DOI: https://doi.org/10.1159/000102122
Edrees F, Li T, Vijayan A. Prolonged Intermittent Renal Replacement Therapy. Adv Chronic Kidney Dis. 2016;23:195-202. DOI: https://doi.org/10.1053/j.ackd.2016.03.003
Newton CRH, Delgado JH, Gomez HF. Calcium and beta receptor antagonist overdose: a review and update of pharmacological principles and management. Semin Respir Crit Care Med. 2002;23:19-25. DOI: https://doi.org/10.1055/s-2002-20585
Love JN, Litovitz TL, Howell JM, Clancy C. Characterization of fatal beta blocker ingestion: a review of the American Association of Poison Control Centers data from 1985 to 1995. J Toxicol Clin Toxicol. 1997;35(4):353-9. DOI: https://doi.org/10.3109/15563659709043366
Kline JA, Leonova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med. 1995;23(7):1251-63. DOI: https://doi.org/10.1097/00003246-199507000-00016
Frishman W, Jacob H, Eisenberg E, Ribner H. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management. Am Heart J. 1979;98(6):798-811. DOI: https://doi.org/10.1016/0002-8703(79)90480-0
Oakes JA, Piquette C, Barthold C. Successful use of intravenous lipid as adjunctive therapy in a severe calcium channel antagonist poisoning Clin Toxicol. 2009;47:755-6.
DeLima LG, Kharasch ED, Butler S. Successful pharmacologic treatment of massive atenolol overdose: sequential hemodynamics and plasma atenolol concentrations. Anesthesiology. 1995;83(1):204-7. DOI: https://doi.org/10.1097/00000542-199507000-00025
Saitz R, Williams BW, Farber HW. Atenolol-induced cardiovascular collapse treated with hemodialysis. Crit Care Med. 1991;19(1):116-8. DOI: https://doi.org/10.1097/00003246-199101000-00026
Sassard J, Pozet N, McAinsh J, Legheand J, Zech P. Pharmacokinetics of atenolol in patients with renal impairment. Eur J Clin Pharmacol. 1977;12:175-80. DOI: https://doi.org/10.1007/BF00609856
Bouchard J, Shepherd G, Hoffman RS, Gosselin S, Roberts DM, Li Y, et al; EXTRIP workgroup. Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. Crit Care. 2021;25(1):201. DOI: https://doi.org/10.1186/s13054-021-03585-7
Pfaender M, Casetti PG, Azzolini M, Baldi ML, Valli A. Successful treatment of a massive atenolol and nifedipine overdose with CVVHDF. Minerva Anestesiol. 2008;74(3):97-100.
Huang SH, Tirona RG, Ross C, Suri RS. Case report: atenolol overdose successfully treated with hemodialysis. Hemodial Int. 2013;17(4):652-5. DOI: https://doi.org/10.1111/hdi.12020
Berbece AN, Richardson RMA. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int. 2006;70(5):963-8. DOI: https://doi.org/10.1038/sj.ki.5001700
Fieghen HE, Friedrich JO, Burns KE; University of Toronto Acute Kidney Injury Research Group. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury. BMC Nephrol. 2010;11:32 DOI: https://doi.org/10.1186/1471-2369-11-32
Downloads
Published
How to Cite
Issue
Section
